La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Sonnet BioTherapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Sonnet BioTherapeutics..

Sonnet BioTherapeutics (NASDAQ:SONN) Azioni, Catena delle Opzioni

Sonnet BioTherapeutics

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Stock,Market,Graph,On,Screen,Display

Equities

News

Markets

PLTR

SONN

TLRY

TSLA

Mercati USA stabili dopo i dazi al 30 % di Trump su UE e Messico. Palantir, Trade Desk, Tilray, Sonnet e Tesla sotto la lente.

Palantir, Trade Desk, Tilray, Sonnet Biotherapeutics e Tesla: 5 titoli nel radar degli investitori

Female,Scientist,Working,In,The,Lab,,She,Is,Wearing,A

Biotech

Health Care

Movers

Trading Ideas

General

Il titolo registra un&#39;impennata dopo l&#39;accordo con Rorschach I, creando Hyperliquid Strategies con 12,6 M HYPE token e 305 M $ in cassa.

Azioni Sonnet BioTherapeutics in forte crescita dopo fusione con Rorschach I e Atlas Merchant

Wall-street-shutter3

Eurozone

Commodities

Intraday Update

DARE

EDHL

FAST

HTOO

NEGG

SQFT

Wall Street mostra un calo nella mattinata USA con Dow Jones, NASDAQ e S&amp;P 500 in ribasso; comunicazioni in verde, energetico in affanno.

Wall Street segna un trend ribassista con Dow Jones e Nasdaq in flessione

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics Holdings Inc

Press Releases

Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy

SONN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Sonnet BioTherapeutics, Inc. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRM, WAT, SONN on Behalf of Shareholders

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders

Small Cap

SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: SONN, SKX, FCCO, and SGBG

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SONN, FCCO, MGRM on Behalf of Shareholders

Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer

Sonnet Releases Virtual Investor "What This Means" Segment

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HBI, BFIN, PBBK, SONN on Behalf of Shareholders

Sonnet to Present at the MedInvest Biotech & Pharma Conference

BFIN

FCCO

MGRM

PBBK

SGBG

VRNA

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

Annovis Bio

AlphaTON Capital

BioAtla

Boundless Bio

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Elutia

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Fortress Biotech

FibroBiologics

Generation Bio

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Kezar Life Sciences

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

NeuroSense Therapeutics Ltd. - Ordinary Shares

NeuroSense Therapeutics

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

Passage Bio

Pluri

Lunai Bioworks

Rein Therapeutics

Senti Biosciences

Tenax Therapeutics

Exicure

XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock

Comments

Sonnet BioTherapeutics

Sonnet BioTherapeutics (SONN) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO